From: Developmental trajectories of executive functions in 22q11.2 deletion syndrome
 |  |  | Diagnostic group | Comparison | ||||
---|---|---|---|---|---|---|---|---|
 |  |  | 22q11.2DS | Controls | t test | Pearson’s chi-square | ANOVA | p value |
N | Â | Â | 95 | 100 | Â | Â | Â | Â |
Gender (male (%)) | Â | Â | 45 (47.36Â %) | 48 (48Â %) | Â | 0.008 | Â | 0.930 |
Age at first time point (mean (SD)) | Â | Â | 12.80 (4.23) | 13.17 (4.43) | 0.596 | Â | Â | 0.552 |
Full-scale IQ at first time point (mean (SD)) | Â | Â | 70.71 (12.27) | 110.37 (13.62) | Â | Â | 454.57 | <0.001 |
VABS outcome measure at last time point (mean (SD)) | Â | ABC score | 66.73 (12.53) | Â | Â | Â | Â | Â |
 |  | Communication score | 71.17 (17.00) |  |  |  |  |  |
 |  | Daily living skills score | 71.06 (15.22) |  |  |  |  |  |
 |  | Socialization score | 73.83 (14.51) |  |  |  |  |  |
Psychiatric diagnosis (N (%)) | Â | Simple phobia | 42 (44.21Â %) | Â | Â | Â | Â | Â |
 |  | Attention deficit disorder | 36 (37.89 %) |  |  |  |  |  |
 |  | Generalized anxiety | 16 (16.84 %) |  |  |  |  |  |
 |  | Major depressive episode | 13 (13.68 %) |  |  |  |  |  |
 |  | Psychosis | 8 (8.42 %) |  |  |  |  |  |
 |  | Obsessive-compulsive disorder | 7 (7.37 %) |  |  |  |  |  |
Psychotropic medication | Total | Â | 39 (41.05Â %) | Â | Â | Â | Â | Â |
 | Categories | Methylphenidate | 26 (66.66 %) |  |  |  |  |  |
 |  | Antidepressants | 12 (30.77 %) |  |  |  |  |  |
 |  | Antipsychotics | 7 (17.95 %) |  |  |  |  |  |
 |  | Antiepileptic | 7 (17.95 %) |  |  |  |  |  |
 |  | Anxiolytic | 3 (7.69 %) |  |  |  |  |  |